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Abstract Eclampsia is one of the leading causes of mater-
nal and perinatal morbidity and mortality in sub-Saharan
Africa. This problem has continued unabated due to lack of
policies supporting financial protection in times of ill health,
non-implementation of proven interventions as well as gaps
in capacity building by stakeholders in health care delivery
in this region. The aim of this retrospective study is to assess
the impact of eclampsia on maternal and perinatal survival
and suggest ways of reducing maternal death. A 6-year
retrospective study was conducted with eighty-three cases of
eclampsia. The cases were mainly antepartum patients with
poor blood pressure control and resultant eclampsia. The
case fatality rate was 8.3% and perinatal death was 24.1%.
Magnesiun sulphate may have contributed to improvements
in pregnancy outcome as mortality was higher among
women with no access to magnesium sulphate. Most of the
eclamptic patients were referred late from private health
facilities hence the need for public-private collaboration in
strengthening the referral system and making magnesium
sulphate widely available in maternal care centers.
Keywords eclampsia; magnesium sulphate; maternal and
foetal outcome
1 Introduction
Eclampsia has been a threat to maternal survival in Nigeria
as one of the major causes of maternal mortality [17]. There
are variations in the reported incidence of eclampsia in
different parts of Nigeria. Eclampsia contributes 31.3%–
43.1% to maternal death in the Northern part of the country
with maternal mortality ratio (MMR) of 1,200 per 100,000
live births [3,18]. Whereas in the South West and South
South parts of the country with much lower MMR of
500/100,000 live births, eclampsia accounts for 27.5% to
40% of deaths [1,7]. The high maternal morbidity and
mortality associated with this condition in this environment
result from low utilization of health facilities and the poor
quality of antenatal care in most of the referring health
facilities. This was evidenced by self referral in patients
who delivered at home or referral from traditional birth
attendants (TBA) and faith based maternity facilities where
basic screening tests could not be carried out [14,17]. Even
in tertiary health facilities in Nigeria, case fatality rate is
still significantly higher compared with developed settings
where high profile life support care is readily available [5].
The aim of this retrospective study was to assess the impact
of eclampsia on maternal and perinatal survival and suggest
ways of reducing maternal death.
2 Methodology
Study site. Nigeria is a federal republic comprising thirty-
six states and one Federal Capital Territory (FCT) within
which is the capital city of Abuja. The three largest and
most influential ethnic groups in Nigeria are the Hausa in
the Northern part, Igbo in South Eastern part and Yoruba
in the South Western part of the country. The country is
divided into six geo-political zones, which include South
West, South South, South East, North West, North East, and
North Central zones; see Figure 1. The study was carried out
in Osun State, South West, Nigeria where the predominant
culture is of the Yoruba ethnic group.
Figure 1: Map of Nigeria showing the geopolitical zones.
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Table 1: Socio-demographic and feto-maternal variables.
Variables Numbers Percentages
Place of ANC
Private hospitals 40 48.2
PHC 18 21.7
General hospitals 16 19.3
Mission homes 7 8.4
TBA 2 2.4
Age (years)



















Gestational age at delivery
< 37 30 36.1
≥ 37 19 22.9
Unknown 34 41.0
Birth weights (kg)
< 2.5 28 33.7
2.5–3.9 32 38.6
≥ 4.0 1 1.2
Unknown 22 26.5
Mean systolic BP on admission (mmHg) 171.5±24.5 Range: 120–250
Mean diastolic BP on admission (mmHg) 111.5±20.0 Range: 66–170
Mean PCV on admission (%) 33.0±6.0% Range: 16–44
Mean proteinuria with dip stick 2.2 Range: 1–3
Mean birth weight (kg) 2.5±0.7 Range: 0.6–4.0
ANC: antenatal care, PHC: primary health care, TBA: traditional
birth attendant, PCV: packed cell volume.
It was a descriptive cross-sectional retrospective 6 year
review of women with eclampsia in a tertiary health facility
in Ladoke Akintola University of Technology Teaching
Hospital, Osogbo, South West, Nigeria between January
1th, 2005 to December 31th, 2010. Case notes of women
who had eclampsia as defined by systolic blood pressure
of ≥ 140 mmHg, diastolic blood pressure of 90 mmHg,
proteinuria of at least 1 plus and convulsions in patients
with no background history of seizure disorder were
retrieved [2]. Demographic information, maternal and
neonatal complications were obtained. Data was analyzed
using SPSS version 14. Continuous variables were summa-
rized with mean and standard deviation while categorical
variables were summarized using number and percentages.
Measure of association was carried out using Fisher’s exact
test and level of significance was put at less than 5%.
Table 2: Feto-maternal complications.
Numbers Percentages
Maternal complication
Acute renal failure 13 15.7
Postpartum haemorrhage 7 8.4
Cerebrovascular accident 3 3.6
Sepsis 1 1.2
Maternal death 7 8.4
Mode of delivery
Caesarean section 45 54.2
Vaginal delivery 33 39.7
Vacuum delivery 5 6.1
Fetal outcome
Neonatal asphyxia 19 22.9
Neonatal death 20 24.1
3 Results
During the review period, a total of 3952 deliveries were
recorded and 83 cases of eclampsia were reported, thus
accounting for an incidence of 2.1%. Mean age was
26.6 ± 6.0 years (15–38 years), parity 1.3 (0–5). Of the
eclamptic women, 51 (71.1%) were treated with magnesium
sulphate. Total maternal mortality from all causes was 71
and total live birth was 3585; thus maternal mortality ratio
over the period was 1981 per 100,000 live birth. Mortality
due to eclampsia was 7 which contributed to 9.9% of total
maternal death and case fatality rate was 8.3%.
Almost half of the referrals were from private health
facilities 40 (48.2%) while 2 (2.4%) were from traditional
birth attendants. With regards to maternal age, majority of
the parturients 44 (63%) were in the 3rd decade of life being
between 20–29 years; while only 10 (12.0%) were teenage
mothers. In terms of parity, the study population was almost
equally distributed between nulliparas 38 (45.8%) and
multiparas 38 (45.8%) with grandmultipara accounting for
only 7 (8.4%). They were mainly of Yoruba ethnic tribe
82 (98.8%).
When feto-maternal complications were analyzed in
Table 1, 30 (36.1%) had preterm deliveries. The incidence
of low birth weight was 33.7% (Table 1). Thirteen (15.7%)
of the parturients had acute renal failure and there were
7 maternal death (case fatality rate 8.4%). Majority
45 (54.2%) had caesarean deliveries, 19 (22.9%) neonatal
asphyxia and 20 (24.1%) perinatal death (Table 2).
After adjusting for postpartum eclampsia, there was no
significant difference in the admission to intensive neona-
tal care unit among the vaginal and caesarean deliveries in
women with antepartum and intrapartum eclampsia. How-
ever, there was significant better neonatal survival among
those who had caesarean deliveries in antepartum eclampsia
compared to those who had vaginal deliveries in the same
group (91.2% versus 9.1%, Fisher’s Exact Test < 0.001)
(Table 3). Majority of the eclamptic women had antepar-
tum eclampsia 45 (54.2%) while intrapartum and postpar-
tum eclamptic women were 19 (22.9%) each; see Figure 2.
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Table 3: Mode of delivery and pregnancy outcome.
Variable CS SVD DF Test statistics P -value
N (%) N (%)
SCBU admission
Antepartum eclampsia
Yes 13 (38.2) 0 (0.0)
No 21 (61.8) 6 (100.0) Fisher’s exact 0.152
Intrapartum eclampsia
Yes 2 (25.0) 3 (27.3)
No 6 (75.0) 8 (72.7) Fisher’s exact 1.000
State of the baby
Antepartum eclampsia
Alive 31 (91.2) 1 (9.1)
Dead 3 (8.8) 10 (90.9) Fisher’s exact 0.000
Intrapartum eclampsia
Alive 6 (75.0) 6 (54.5)
Dead 2 (25.0) 5 (45.5) Fisher’s exact 0.633
CS: caesarean section.
SVD: spontaneous vaginal delivery.
SCBU: special care baby unit.
DF: degree of freedom.
N : number.
4 Discussion
Eclampsia has remained one of the major causes of maternal
morbidity and mortality in sub-Saharan Africa, contribut-
ing 9.9% of the maternal death in the study period. The
incidence of eclampsia varies from one geographical area
of Nigeria to another. Its incidence in the study population
was 2.1% which was higher than that reported in the FCT,
estimated at 1.3%, whereas Sagamu sharing the same south
west geo-political zone as the study location has 1.7% and
Benin in the middle eastern part of the country reported
1.3% [5,6,12]. The mean age and age range of eclamptic
women in our study was similar to the report from Benin and
FCT [5,14]. The proportion of nulliparous women from our
study is 45.8% [5] which is lower than the report from the
Northern region (60.9%) and Middle Eastern part (52.4%)
of the country. The higher proportion of nulliparity observed
among women with eclampsia in north and eastern Nige-
ria is in support of the fact that first deliveries take place
mostly at extremes of age, below 20 years and above 35
years. Also the incidence of teenage pregnancies was higher
in the regions that had the higher proportions.
The quality of care a woman receives in prenatal care has
a significant impact on the outcome of the pregnancy. All the
women in our study were not booked in our health facility
which is a tertiary teaching hospital but this is not necessar-
ily to be interpreted as a negative development. Within the
Nigerian health system, teaching hospitals are tertiary refer-
ral centers while primary health centers serve a gate-keeping
function. The policy of the ministry of health regarding ante-
natal care encourages women to receive such care in pub-
lic or private primary and secondary health facilities while
tertiary centers, such as ours, are expected to act as refer-
ral facilities for high risk patients. This may explain the
observation that a large proportion of patients in this study
Figure 2: Types of eclampsia.
were initially booked in private health facilities (48.2%) and
primary health facilities (21.7%) and then referred to our
center. Another explanation for this finding which has impli-
cations for pregnancy outcome may be the financial burden
of antenatal care. The antenatal fees charged in a primary
health facility are often much lower than fees charged in
tertiary facilities.
The additional finding that more than half (54.2%) had
antepartum eclampsia is in support of reports from other
centres in the country [4,5,6,8,10,11,12]. This implies that
prompt and proper management of the situation early on
in the pregnancy or expedited referral to a tertiary center
may have improved feto-maternal outcome in the study
population. Significant proportion (71.1%) of the cases
studied had magnesium sulphate with case fatality rate
of 8.3% which was similar to 8.5% reported in the FCT
having similar treatment modality [5]. However, this is
unacceptably higher than the maximum recommended 1%
by United Nations [16]. A decade before this current study,
the case fatality for eclampsia was significantly higher with
10.7% reported in Middle Eastern part and 22.3% in the
Northern part of the country. This can be attributed to the
fact that diazepam was the only anticonvulsant available
[14] for management of eclampsia [9]. The improvement
observed in our study underscores the better outcome
associated with the administration of magnesium sulphate.
However, a lot more needs to be done to reduce high fatality
rate in our environment. The mean systolic blood pressure
was 171 mmHg (±24.1) while the diastolic blood pressure
was 111.5 mmHg (±20.1). This observed poor blood
pressure control with mean significant proteinuria of 2.2
pluses of dip stick might have contributed significantly to
high case fatality rate recorded in this study. The commonest
maternal morbidity recorded was acute renal failure which
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corroborates the report from FCT [5] but in contrast to
report from Benin where the commonest complication
was cerebrovascular disease. This could be due to fact that
diazepam alone was used in management of eclampsia in the
Benin centre which is not as effective magnesium sulphate
in controlling recurrent convulsions [14]. The perinatal
mortality rate of 24.1% reported in this study though higher
than that reported in FCT 17.4% [5] is much lower than
those of the Northern parts 34.6% and 31.7% where among
other factors, unavailability of magnesium sulphate could
be a contributor to poorer neonatal outcome [9,15]. This
further stresses the benefit of magnesium sulphate for better
neonatal outcome.
Majority of the patients 54.2% had caesarean section
supporting findings from other studies [5,12,13]. Adjusting
for postpartum eclampsia, neonatal survival was signif-
icantly associated with caesarean deliveries compared to
vaginal deliveries among women with antepartum eclampsia
thus making caesarean delivery a better option of mode
of delivery in these women presenting with antepartum
eclampsia.
This study demonstrated no difference in neonatal out-
come among women with intrapartum eclampsia, a larger
study might be necessary to show any difference.
5 Conclusion
Sub-Saharan Africa accounts for more than 90% of maternal
deaths worldwide today and eclampsia is still a major pre-
ventable health challenge contributing significantly to this
statistic. This study has weighted the impact of eclampsia
on MMR and made suggestions for reducing mortality asso-
ciated with childbirth especially in light of the deadline for
meeting the Millenium Development Goals in 2015. The
observation that most cases were referred from public and
private primary health facilities where the quality of care is
not optimal raises the need for regulatory authorities to part-
ner with private health practitioners in improving the quality
of antenatal care. It is equally important to strengthen the
referral system in all these health care facilities to expe-
dite prompt referral especially in cases with life-threatening
conditions like eclampsia. This study has also documented
improvements in maternal and neonatal outcome achieved
with the use of magnesium sulphate rather than diazepam. A
precedent of synergistic public-private partnership has been
set with availability of anti-retroviral drugs for the treat-
ment of HIV. It is therefore imperative that governments in
developing countries collaborate with pharmaceutical com-
panies in encouraging local production of magnesium sul-
phate which can then be made available at affordable cost.
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